Ignacio Durán is a medical oncologist with interests in clinical and translational research and medical education. He is the Leader of the Genitourinary Oncology Program at the Medical Oncology Department at the Hospital Universitario Marques de Valdecilla in Santander, Spain.
Dr Durán earned his medical degree in 1997 at the Universidad de Salamanca and went on to attain his doctorate in 2005 at the Universidad Complutense with highest commendation. Between 2004 and 2007, he completed a fellowship in drug development and genitourinary tumours at the Princess Margaret Cancer Centre in Toronto, Canada, and received a Master’s Degree in the teaching of medicine at the University of Toronto.
Dr Durán is a member of the American Society of Clinical Oncology, the European Society of Medical Oncology, the European Association of Urology and the Spanish Society of Medical Oncology. He is president and co-founder of GO NORTE, a collaborative group of Spanish medical oncologists with interest in GU oncology of the North area of Spain including over 25 hospitals.
His major research interests include genitourinary tumours and anticancer clinical drug development. He has authored numerous publications covering diverse areas of medical oncology in peer-reviewed scientific journals. Throughout his career, Dr Durán is recipient of the ASCO Foundation Merit Award, the Novartis Young Canadian Investigator Award and the University Health Network Outstanding Research Presentation Award.
Disclosures
Ignacio Durán discloses the following relationships and financial interests: he has been an invited speaker, has participated in compensated activities, has been an advisor or received funding/grants with the following companies over the past two years: ASTELLAS, Bristol Myers Squibb, EUSA PHARMA, Immunomedics, Inc., IPSEN, Jansen, MSD, Novartis, PFIZER, Roche Genentech and Astra Zeneca.
Non-financial Interests
Dr Durán has been a Member of the board of Directors for ASEICA and has been an external advisor to the board of directors of the Spanish Association of cancer research since 2021. At GO NORTE he has a Leadership Role whereby he is the president of an independent cooperative group of GU Oncologists from the North of Spain.
All relevant financial relationships have been mitigated.